Oncotelic Therapeutics Announces Publication Showing TGFB2 Methylation as Positive Prognostic Marker in Pancreatic Cancer

Oncotelic Therapeutics announced the publication of a study in the *International Journal of Molecular Sciences* showing that TGFB2 gene methylation i...

Empowering Life Sciences with
Advanced AI Solutions.

Book A Demo
HomeKnolsightsContact UsPricing
One Research Ct, Suite 450 Rockville, MD, 20850
info@pienomial.com
+91 9876543210
Copyright © 2025. All rights reserved
AboutTerms of ServicePrivacy Policy
Home/KnloSights/Clinical Trial Updates/Oncotelic Therapeutics Announces Publication Showing TGFB2 Methylation as Positive Prognostic Marker in Pancreatic Cancer